Inventor
WATERSON DAVID
AU34 patents
⚠️ This page may combine multiple inventors who share the name “WATERSON DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ICI PLC
13 patentsUS5403857AApr 4, 1995
Benzenesulphonamide derivatives having 5-lipoxygenase inhibitory activity
ICI PLC25 citations92
US5298511AMar 29, 1994
Alkanoic acid derivatives
ICI PLC49 citations92
US5236948AAug 17, 1993
Sulphonamide derivatives
ICI PLC11 citations74
US5254581AOct 19, 1993
Pyran derivatives and their use as inhibitors of 5-lipoxygenase
ICI PLC7 citations73
US5126365AJun 30, 1992
Bicyclic derivatives
ICI PLC10 citations71
US5519022AMay 21, 1996
α, α dialkylbenzyl derivatives
ICI PLC3 citations63
US5288742AFeb 22, 1994
α,α dialkylbenzyl derivatives
ICI PLC4 citations63
US5254697AOct 19, 1993
Process for the preparation of haloalkyllactones
ICI PLC3 citations63
US5091425AFeb 25, 1992
5-(heterocyclylalkanoyl)amino-4-hydroxypentanamides
ICI PLC6 citations63
US5260442ANov 9, 1993
Process for the manufacture of crystalline quinolinium salts and their oxidation to 1-alkyl-2-quinolones
ICI PLC3 citations60
US5232930AAug 3, 1993
2-heteroaryl-substituted benzodioxoic having 5-lipoxygenase inhibitory activity
ICI PLC5 citations60
US5314891AMay 24, 1994
Benzenesulphonamide derivatives
ICI PLC1 citations52
US5258399ANov 2, 1993
Sulphonamide derivatives
ICI PLC1 citations52
ASTRAZENECA AB
8 patentsUS6734184B1May 11, 2004
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
ASTRAZENECA AB20 citations87
US7485644B2Feb 3, 2009
N-{'4-substituted piperazine-1-sulfonylmethylalkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors
ASTRAZENECA AB2 citations62
US7122551B2Oct 17, 2006
Metalloproteinase inhibitor compounds
ASTRAZENECA AB2 citations61
US6734183B2May 11, 2004
Compounds
ASTRAZENECA AB5 citations56
US7342020B2Mar 11, 2008
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
ASTRAZENECA AB0 citations52
US7906645B2Mar 15, 2011
Heterocyclic compounds as ccr2b antagonists
ASTRAZENECA AB1 citations48
US8710224B2Apr 29, 2014
Heterocyclic compounds as CCR2B antagonists
ASTRAZENECA AB0 citations47
US7153857B2Dec 26, 2006
Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
ASTRAZENECA AB0 citations39
ZENECA LTD
6 patentsUS6313127B1Nov 6, 2001
Heterocyclic compounds useful as pharmaceutical agents
ZENECA LTD139 citations96
US6093718AJul 25, 2000
Substituted pyrimidine derivatives and their pharmaceutical use
ZENECA LTD46 citations92
US6090813AJul 18, 2000
Use of oxido-squalene cyclase inhibitors to lower blood cholesterol
ZENECA LTD5 citations62
US5446165AAug 29, 1995
Crystalline 1-alkyl-2-quinolinium salts
ZENECA LTD1 citations49
US6680183B2Jan 20, 2004
Production of optically active 2-substituted tetrahydropyran-4-ones
ZENECA LTD0 citations48
US6258574B1Jul 10, 2001
Production of optically active 2-substituted tetrahydropyran-4-ones
ZENECA LTD1 citations48